Hodges Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Hodges Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,000	Closed	-$1.97M	–	251
2018 Q1	$1.97M	Buy	+1,000	New	+$77.3K	0.16%	118
2015 Q2	–	Sell	-25,000	Closed	-$2.36M	–	292
2015 Q1	$2.36M	Sell	25,000 -65,000	-72%	-$7.28M	0.09%	135
2014 Q4	$10.1M	Sell	90,000 -40,000	-31%	-$3.57M	0.41%	89
2014 Q3	$7.97M	Buy	+130,000	New	+$5.6M	0.33%	111

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Hodges Capital Management's AGIO Position: Q2 2018 in Review

Hodges Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2018, closing a stake of 1,000 shares — an estimated $1.97M sold.

Hodges Capital Management first reported a position in AGIO in Q3 2014 and held it in 4 quarters. The position peaked at $10.1M in Q4 2014. 217 funds tracked by Wall St. Rank hold AGIO as of Q2 2018.

Hodges Capital Management reported no remaining Agios Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Hodges Capital Management sold 1,000 Agios Pharmaceuticals shares in Q2 2018, an estimated $1.97M.
Hodges Capital Management first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 4 quarters.
Hodges Capital Management's Agios Pharmaceuticals position peaked at $10.1M in Q4 2014.
217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2018.

Based on Hodges Capital Management's 13F filing for Q2 2018, filed 26 Jul 2018.